[{"Assets_0_Q3_USD":2519947000.0,"CommonStockSharesOutstanding_0_Q3_shares":212754024.0,"EarningsPerShareBasic_1_Q3_USD":0.14,"EarningsPerShareBasic_3_Q3_USD":0.19,"EarningsPerShareDiluted_1_Q3_USD":0.14,"EarningsPerShareDiluted_3_Q3_USD":0.19,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":252389000.0,"NetIncomeLoss_1_Q3_USD":29176000.0,"NetIncomeLoss_3_Q3_USD":40430000.0,"StockholdersEquity_0_Q3_USD":1802899000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":215964000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":215516000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":212627000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":212172000.0,"Ticker":"INCY","CIK":"879169","name":"INCYTE CORP","OfficialName":"Incyte Corp. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17588712770.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"SP500","filed":"20181030"}]